Zeon and Sino Applied Technology Join Hands to Expand Single-Walled Carbon Nanotube Conductive Paste Product Line and Promote the Application of Next-Generation Lithium Batteries in Electric Vehicles
Zeon Corporation (Zeon) and Sino Applied Technology (SiAT) are thrilled to announce the signing of a strategic partnership in Taoyuan, Taiwan. As part of this collaboration, Zeon will lead a $20 million USD Series C fundraising round in SiAT to support the expansion of its production capacity for single-walled carbon nanotube (SWCNT) conductive paste, a critical nanomaterial for next-generation battery technologies.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250511242604/en/
ZEONANO®, Single-Walled Carbon Nanotube produced by Zeon Super Growth Method
The global demand for lithium-ion batteries is surging across consumer applications—such as electric vehicles, drones, and EVTOL aircraft—as well as industrial sectors, including AI server BBUs, renewable energy ESS, and automated robotics. This growth has intensified the need for SWCNTs, which can significantly enhance battery energy density and cycle life. Unlike traditional conductive agents like carbon black or multi-walled carbon nanotube slurries, SWCNT conductive paste offers superior electrical conductivity, mechanical strength, and chemical stability, making it increasingly vital for advanced battery formulations.
Mass production of SWCNT powder presents significant challenges due to the high-temperature chemical vapor deposition (CVD) process, which requires precise control of catalysts and reaction conditions to achieve both high yield and high purity. Zeon is the first company globally to achieve mass production of SWCNTs in 2015. Utilizing its proprietary Super Growth technology, Zeon produces ZEONANO®, SWCNT product characterized by high aspect ratio, high purity, and large surface area.
Another key challenge in SWCNT adoption is dispersion. SWCNTs tend to bundle and exhibit poor dispersibility in both aqueous and non-aqueous media, complicating their uniform integration into electrode slurries during battery manufacturing. SiAT team, with over 20 years of expertise in battery nanomaterials, brings proprietary know-how to this partnership, enabling the even dispersion of SWCNTs into stable conductive paste product tailored for battery electrodes.
Since 2024, Zeon and SiAT have successfully collaborated to introduce well-dispersed SWCNT conductive pastes—LSC2102 (NMP-based) and LSC1101 (water-based). These products have undergone rigorous evaluation by battery manufacturers, demonstrating that incorporating a very small amount of SWCNTs into lithium battery cathodes and anodes can enhance energy output and cycle life, which is particularly critical for silicon anodes and other high-capacity, high-rate performance applications.
Zeon is the lead investor in SiAT’s $20 million Series C funding round, joined by other prominent Taiwanese venture partners. With this funding, SiAT aims to scale its annual conductive paste production capacity to 25,000 tons by 2030. Concurrently, Zeon will fulfill its role as the primary supplier to SiAT.
Beyond battery applications, SWCNTs hold transformative potential across multiple industries, including metal, rubber, and plastic composites, semiconductors, and more. Their unique properties enable innovations in high-conductivity functional rubber, high-thermal-conductivity materials, structural reinforcements, and high-performance membranes. SiAT will continue working alongside Zeon to expand SWCNT applications across industries. Through Zeon’s world-leading innovations and SiAT’s industry expertise, the partnership aims to contribute to environmental sustainability and technological progress for global green transition.
About Zeon
Zeon (Zeon Corporation, TYO:4205) is a world leader in specialty elastomers, polymers, and specialty chemicals. With over 75 years in business and consolidated sales of over U.S. $2.5 billion, Zeon has both the experience and the expertise in C4 and C5 chemistry to offer a wide range of products. Zeon Corporation employs over 4,000 people worldwide, with global headquarters in Tokyo and regional headquarters in the United States, Singapore, and Germany.
About SiAT
SiAT (Sino Applied Technology) is a Taiwan manufacturer of advanced nanomaterials for next-generation batteries. Established in 2018, SiAT’s core mission is to accelerate green transition by increasing battery performance through its innovative nanomaterials. SiAT owns several US & Europe patents in nanomaterial production. SiAT is scaling its technology at its manufacturing facility in Taiwan, and now offers innovative products including CNT conductive paste, LMFP paste, CNT-coated aluminum foil and nano silicon anode.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250511242604/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
TreeFrog Therapeutics Presents Delivery Strategy for Next Generation 3D Cell Therapy Format for Parkinson’s Disease at the 28th Annual ASGCT Meeting in New Orleans13.5.2025 08:00:00 CEST | Press release
TreeFrog Therapeutics is the first company to present publicly a clinical-ready delivery strategy for 3D format microtissues in cell therapy.After four years in development, the validated device and delivery strategy overcomes challenges of 3D formats and uses existing stereotactic components to support adoption through ease of delivery education. TreeFrog Therapeutics, a French biotech specializing in cell therapy is the first company to present a clinical-ready delivery strategy for 3D microtissues cell therapy. The validated approach was demonstrated for their 3D neural microtissues cell therapy treatment for Parkinson’s disease. Parkinson’s disease is the second most common neurodegenerative disorder after Alzheimer’s disease. It is a progressive disease characterized by the loss of dopaminergic neurons with a mix of motor symptoms (bradykinesia, rigidity, resting tremor) and non-motor symptoms (cognitive deficits, mood disorders, fatigue). Current treatments provide symptomatic re
Ohana Development Launches ‘Jacob & Co. Beachfront Living by Ohana,’ A Masterpiece of Beachfront Elegance in the UAE13.5.2025 08:00:00 CEST | Press release
Valued at USD 1.3 billion, the project offers world-class amenities, including a signature Jacob & Co. ceiling art timepiece, the largest of its kind globally. Ohana Development, the leading real estate developer renowned for its luxury properties, has launched ‘Jacob & Co. Beachfront Living by Ohana’ in partnership with luxury timepiece and jewellery house Jacob & Co. The project was revealed at Emirates Palace Mandarin Oriental, Abu Dhabi. Located in Al Jurf between Dubai and Abu Dhabi, this USD 1.3 billion development blends natural surroundings with exceptional artistry and craftsmanship. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250512533615/en/ Jacob & Co. Beachfront Living by Ohana. (Photo: AETOSWire) Jacob & Co. Beachfront Living by Ohana presents 457 residences comprising of sea-view apartments, villas, penthouses, Sky Mansions, and beachfront mansions—each capturing the spirit of refined coastal living. Pentho
Azafaros Secures € 132M in Oversubscribed Series B Financing to Advance Phase 3 Clinical Programs of Innovative Therapies in Lysosomal Storage Disorders13.5.2025 07:00:00 CEST | Press release
Financing round led by Jeito Capital and co-led by Forbion Growth, with participation from Seroba, Pictet Group and other existing investorsProceeds to fund two Phase 3 pivotal programs with nizubaglustat, lead asset in Niemann-Pick disease Type C (NPC) and GM1/GM2 gangliosidoses as well as expanding the Azafaros pipeline to other indicationsNizubaglustat has been awarded Orphan Drug Designation in both the US and Europe as well as Fast-track status in the US. The company expects to initiate both Phase 3 studies later this year Azafaros, a clinical-stage company focused on developing disease-modifying therapeutics to offer new treatment options to patients with rare lysosomal storage disorders, announces the completion of an oversubscribed €132M Series B financing led by Jeito Capital, co-led by Forbion Growth and with additional participation from Seroba, Pictet Group and existing investors Forbion Ventures, Schroders Capital and BioGeneration Ventures (BGV). This financing enables Az
Presidio Investors is Pleased to Announce the Addition of Christian Schütte as Its Newest Operating Partner12.5.2025 19:04:00 CEST | Press release
Christian brings more than 20 years of global experience in investment banking, private equity, and operational leadership, with a proven track record of driving transformational growth across industries. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250512473756/en/ Christian Schütte Christian began his career at J.P. Morgan in New York and London, where he worked in the M&A and Corporate Finance teams. He later joined Fortress Investment Group and was instrumental in launching its German operations. During his tenure, he helped raise over €1.5 billion in equity and managed a wide array of investments, including non-performing and performing loans, private and public companies. He went on to join EQT Group, where he focused on mid-market growth and succession investments. Notably, he led the consolidation of nine digital marketing agencies into a €100 million market leader, building one of the most comprehensive digital ma
Introducing Joblio – The Future of Ethical Recruitment12.5.2025 18:30:00 CEST | Press release
Joblio Launches to Revolutionize Ethical Recruitment and End Worker Exploitation Joblio, a global ethical recruitment platform, officially launches today to tackle the broken labor migration system—long plagued by exploitative intermediaries, high recruitment fees, and human rights abuses. With its tech-driven model, Joblio connects vetted workers with employers directly, eliminating unethical middlemen and ensuring cost-free hiring for migrant workers. Employers fund access to talent, but workers never pay—a key step in ending exploitation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250512628048/en/ A Mission Rooted in Personal Experience Joblio is led by Jon Purizhansky, a refugee-turned-entrepreneur who experienced migration challenges firsthand. Forced to flee his home country as a young man, Jon faced the uncertainty and vulnerability that millions of migrant workers still encounter today. Now a globally recognized
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom